
|Articles|April 27, 2003
Diagnostic profile measures stone formation risk factors
Mission Pharmacal offers the StoneRisk Diagnostic Profile, which measures10 urine risk factors for stone formation. It offers a urine collectionand preservation system and is recommended for initial and recurrent stoneformers who test positive for a urinary tract infection, according to thecompany. Test results are shown on a computer-generated graphic display.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
FDA approves first-line Zenflow system for the treatment of BPH
5















